| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/2008 | CA2262997C Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2256022C 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 07/29/2008 | CA2254914C Methods of terminal sterilization of biological products |
| 07/29/2008 | CA2254070C Method for treating viral infections |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2214086C Pyrazole derivatives and processes for the preparation thereof |
| 07/29/2008 | CA2207144C A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof |
| 07/29/2008 | CA2203033C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2201377C Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 07/29/2008 | CA2199809C Synthetic ganglioside derivatives |
| 07/29/2008 | CA2190377C Use of topical treatment compositions comprising alpha hydroxy acid in the treatment of striae distensae |
| 07/29/2008 | CA2183471C Method and device for the provocation of air passage narrowing and/or the induction of sputum |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/29/2008 | CA2168192C 4-aminobenzoylguanidine derivatives |
| 07/29/2008 | CA2147882C Bifidobacterium growth promotant |
| 07/29/2008 | CA2110490C Drug delivery systems comprising gas-filled liposomes at least 90% devoid of liquid in their interior |
| 07/25/2008 | CA2617463A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/24/2008 | WO2008089464A1 Prodrugs of substituted 1,3-dioxanes and their uses |
| 07/24/2008 | WO2008089463A2 Substituted 1,3-dioxanes and their uses |
| 07/24/2008 | WO2008089462A2 Substituted 1,3-dioxanes and their uses |
| 07/24/2008 | WO2008089461A1 Substituted 1,3-dioxanes useful as ppar modulators |
| 07/24/2008 | WO2008089459A1 Inhibitors of mek |
| 07/24/2008 | WO2008089453A2 Inhibitors of d-amino acid oxidase |
| 07/24/2008 | WO2008089426A2 Methods and compositions for the delivery of a therapeutic agent |
| 07/24/2008 | WO2008089405A1 Composition of multiple hormones delivered vaginally in a single cream |
| 07/24/2008 | WO2008089403A2 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 07/24/2008 | WO2008089390A1 New classical antifolates |
| 07/24/2008 | WO2008089389A2 Treatment of cancers with acquired resistance to kit inhibitors |
| 07/24/2008 | WO2008089388A2 Treatment of cancers having resistance to chemotherapeutic agents |
| 07/24/2008 | WO2008089310A2 Delta 5 desaturase inhibitors for the treatment of obesity |
| 07/24/2008 | WO2008089307A2 Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer |
| 07/24/2008 | WO2008089296A1 Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents |
| 07/24/2008 | WO2008089283A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases |
| 07/24/2008 | WO2008089272A1 Formulations for cancer treatment |
| 07/24/2008 | WO2008089260A2 Combined administration of benzonatate and guaifenesin |
| 07/24/2008 | WO2008089242A1 Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic |
| 07/24/2008 | WO2008089201A2 Heterocyclic-substituted piperidine as orl-1 ligands |
| 07/24/2008 | WO2008089185A2 Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugates thereof |
| 07/24/2008 | WO2008089148A1 Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug |
| 07/24/2008 | WO2008089126A2 Cd45 and methods and compounds related thereto |
| 07/24/2008 | WO2008089125A2 Antiviral compounds and methods of using thereof |
| 07/24/2008 | WO2008089113A2 Method and apparatus for making uniformly sized particles |
| 07/24/2008 | WO2008089112A2 Uniformly sized liposomes |
| 07/24/2008 | WO2008089105A2 Antiviral nucleoside analogs |
| 07/24/2008 | WO2008089103A2 Targeting ncca-atp channel for organ protection following ischemic episode |
| 07/24/2008 | WO2008089102A2 Compositions and methods for enhancing tolerance for the production of organic chemicals produced by microorganisms |
| 07/24/2008 | WO2008089087A2 Tablet-in-tablet compositions |
| 07/24/2008 | WO2008089052A2 N-substituted glycine derivatives: hydroxylase inhibitors |
| 07/24/2008 | WO2008089051A1 N-substituted glycine derivatives: prolyl hydroxylase inhibitors |
| 07/24/2008 | WO2008089034A2 Cytokine inhibitors |
| 07/24/2008 | WO2008089027A1 Compounds for the treatment of hepatitis c |
| 07/24/2008 | WO2008089015A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/24/2008 | WO2008089008A2 Tetrahydrobiopterin prodrugs |
| 07/24/2008 | WO2008089005A2 Renin inhibitors |
| 07/24/2008 | WO2008088987A1 Treatment of pain with naloxone |
| 07/24/2008 | WO2008088937A1 Quinolynylmethylimidizoles as therapeutic agents |
| 07/24/2008 | WO2008088936A1 Quinolynylmethylimidizoles as therapeutic agents |
| 07/24/2008 | WO2008088935A2 Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives |
| 07/24/2008 | WO2008088927A1 Pharmaceuticals, compositions and methods of making and using the same |
| 07/24/2008 | WO2008088909A1 Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives |
| 07/24/2008 | WO2008088902A2 Attenuation of the adaptive immune response |
| 07/24/2008 | WO2008088900A2 Polymorphic forms of rimonabant base and processes for preparation thereof |
| 07/24/2008 | WO2008088881A1 Kinase inhibitor compounds |
| 07/24/2008 | WO2008088873A1 Peracetic teat dip |
| 07/24/2008 | WO2008088864A2 Matrix metalloproteinase-9-related methods |
| 07/24/2008 | WO2008088852A2 Method of using squalene monooxygenase inhibitors to treat acne |
| 07/24/2008 | WO2008088820A2 Glutamate receptor antagonists and methods of use |
| 07/24/2008 | WO2008088810A2 Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markers |
| 07/24/2008 | WO2008088806A1 Combinational paradigm combating hiv, hiv/hsv, or hiv/hpv infections in humans using small molecular weight compounds from plants |
| 07/24/2008 | WO2008088803A2 Formulations for parenteral administration of (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones |
| 07/24/2008 | WO2008088779A2 Solid state forms of 5-azacytidine and processes for preparation thereof |
| 07/24/2008 | WO2008088756A1 Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus |
| 07/24/2008 | WO2008088727A2 Endothelin receptor antagonists |
| 07/24/2008 | WO2008088689A1 Substituted spirochromanone derivatives as acc inhibitors |
| 07/24/2008 | WO2008088688A1 Substituted spirochromanone derivatives as acc inhibitors |
| 07/24/2008 | WO2008088617A1 Treatment of copd |
| 07/24/2008 | WO2008088612A1 Method of stimulating the production of mucin in the eye of a patient |
| 07/24/2008 | WO2008088538A2 Esters of 2-phenylalkanenitriles and antifungal compositions containing them |
| 07/24/2008 | WO2008088415A1 Omega-3 fatty acids for reduction of lp-pla2 levels |
| 07/24/2008 | WO2008088233A1 Therapeutical uses of eslicarbazepine |
| 07/24/2008 | WO2008088147A1 Maleic acid monosalt of antiviral agent and pharmaceutical composition containing the same |
| 07/24/2008 | WO2008088088A1 Composition for treatment of pancreatic cancer |
| 07/24/2008 | WO2008088047A1 Method for glycosylation of flavonoid |
| 07/24/2008 | WO2008088039A1 Stabilized medicinal composition containing donepezil, method of producing the same and method for stabilization |
| 07/24/2008 | WO2008088037A1 Finely particulate medicinal preparation |
| 07/24/2008 | WO2008088030A1 Composition for prevention or treatment of disease associated with thrombus or embolus |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008087936A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087882A1 Intragastric floating-type levodopa sustained-release preparation |
| 07/24/2008 | WO2008087862A1 Agent against periodontal disease |
| 07/24/2008 | WO2008087705A1 Composition for inhibiting muscle damage |
| 07/24/2008 | WO2008087704A1 Composition for improving brain function |
| 07/24/2008 | WO2008087654A2 PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 07/24/2008 | WO2008087650A2 Composition and method for treating or preventing skeletal muscle fibrosis |
| 07/24/2008 | WO2008087643A2 Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors |
| 07/24/2008 | WO2008087529A1 Nicotinic acetylcholine receptor modulators |